Combination of 2-methoxy-3-phenylsulfonylaminobenzamide and 2-aminobenzothiazole to discover novel anticancer agents

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity

Sauveur-Michel Maira, Frédéric Stauffer, Josef Brueggen et al. · Molecular Cancer Therapeutics · 2008 · 1.1K citations · Full text

Tenets of PTEN Tumor Suppression

Leonardo Salmena, Arkaitz Carracedo, Pier Paolo Pandolfi · Cell · 2008 · 1K citations · Full text

Tumor Biology, Perineural Invasion, Pathology +5

The Entropic Cost of Bound Water in Crystals and Biomolecules

Jack D. Dunitz · Science · 1994 · 575 citations

Crystal Formation, Biophysics, Solution (Chemistry) +1

Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin

Steven D. Knight, Nicholas D. Adams, Joelle L. Burgess et al. · ACS Medicinal Chemistry Letters · 2010 · 367 citations · Full text

Highly Potent Inhibitor, Tumor Biology, Mammalian Target +16

mTOR mediated anti-cancer drug discovery

Qingsong Liu, Carson C. Thoreen, Jinhua Wang et al. · Drug Discovery Today Therapeutic Strategies · 2009 · 171 citations · Full text

Medicine, Anti-cancer Drug Discovery, Anti-cancer Agent +4